Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANAKINUMAB vs CANNABIDIOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANAKINUMAB vs CANNABIDIOL: Safety Overview

Metric CANAKINUMAB CANNABIDIOL
Total FAERS Reports 10,462 18,243
Deaths Reported 518 1,563
Death Rate 5.0% 8.6%
Hospitalizations 2,624 5,149
Average Patient Age 28.8 yrs 21.6 yrs
% Female Patients 55.8% 45.2%
FDA Approval Date N/A Sep 28, 2018
Manufacturer Novartis Pharmaceuticals Corporation Jazz Pharmaceuticals, Inc.
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription